Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results Jan 22, 2015 04:01PM
Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer Jan 15, 2015 04:01PM
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome Jan 12, 2015 04:01PM
Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference Jan 8, 2015 04:15PM
Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies Jan 5, 2015 09:00AM

Dec 22, 2014 09:15AM Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts
Dec 17, 2014 05:45PM Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend
Dec 11, 2014 04:01PM Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Dec 8, 2014 09:00PM Amgen Presents Data From Pivotal Phase 2 Study Of BLINCYTO™ (blinatumomab) Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Dec 8, 2014 04:20PM New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA® (Pembrolizumab) For Advanced Melanoma
Dec 8, 2014 09:00AM FDA Approves Amgen's XGEVA® (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy
Dec 6, 2014 01:00PM Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Dec 6, 2014 11:00AM Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
Dec 3, 2014 07:00PM Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition
Dec 3, 2014 04:30PM Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources
Dec 3, 2014 03:48PM FDA Approves BLINCYTO™ (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Nov 25, 2014 04:01PM Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Nov 24, 2014 09:15AM Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
Nov 18, 2014 04:00PM Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels
Nov 14, 2014 04:15PM Amgen To Present At The Jefferies Global Healthcare Conference
Nov 12, 2014 04:35PM Amgen To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions
Nov 12, 2014 04:01PM Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab
Nov 12, 2014 09:00AM The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide
Nov 11, 2014 04:01PM Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Nov 10, 2014 09:15AM FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Nov 6, 2014 04:30PM Amgen To Present At The Credit Suisse Annual Healthcare Conference
Nov 6, 2014 04:01PM Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014
Nov 4, 2014 09:00AM Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer
Oct 28, 2014 09:33AM Pre-Open Stock Movers 10/28: (RCPT) (TRNX) (VDSI) (MSG) Higher; (TWTR) (AMKR) (CVLT) Lower (more...)
Oct 28, 2014 08:48AM Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans
Oct 27, 2014 06:22PM After-Hours Stock Movers 10/27: (TRNX) (RCPT) (SANM) Higher; (AKMR) (TWTR) (KSS) Lower (more...)
Oct 27, 2014 04:01PM Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30
Oct 14, 2014 10:03AM UPDATE: Gilead Sciences (GILD) Hits Session Lows
Jul 30, 2014 10:29AM Top 10 Trending Stocks for 07/30: Twitter (TWTR), Amgen (AMGN), Regeneron (REGN), and More...
Jul 30, 2014 09:32AM Pre-Open Stock Movers 7/30: (GFIG) (TWTR) (NQ) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
Jul 29, 2014 06:10PM After-Hours Stock Movers 7/29: (TWTR) (ZLTQ) (X) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
Jul 29, 2014 05:37PM Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple
Jul 28, 2014 05:11PM Trading Radar for 07/29: Pfizer (PFE), Marriott (MAR), UPS (UPS), Anadarko (APC), Ballard Power (BLDP) Report